AXL and neuroblastoma: demonstrated that targeting Axl with its inhibitor has been shown to suppress neuroblastoma cell metastasis by regulating tumor-driven angiogenesis, which highlights its potential as a promising therapeutic target for neuroblastoma treatment (112).